Alan Ezekowitz - Net Worth and Insider Trading
Alan Ezekowitz Net Worth
The estimated net worth of Alan Ezekowitz is at least $4 Million dollars as of 2026-07-27. Alan Ezekowitz is the Director of Septerna Inc and owns about 117,420 shares of Septerna Inc (SEPN) stock worth over $4 Million. Alan Ezekowitz is also the Director of Fulcrum Therapeutics Inc and owns about 10,927 shares of Fulcrum Therapeutics Inc (FULC) stock worth over $40,703. Details can be seen in Alan Ezekowitz's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Alan Ezekowitz has not made any transactions after 2026-06-26 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Alan Ezekowitz
Alan Ezekowitz Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Alan Ezekowitz owns 3 companies in total, including Fulcrum Therapeutics Inc (FULC) , Organon & Co (OGN) , and Septerna Inc (SEPN) .
Click here to see the complete history of Alan Ezekowitz’s form 4 insider trades.
Insider Ownership Summary of Alan Ezekowitz
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| FULC | Fulcrum Therapeutics Inc | 2026-06-26 | director |
| OGN | Organon & Co | 2021-06-02 | director |
| SEPN | Septerna Inc | 2024-10-24 | director |
Alan Ezekowitz Latest Holdings Summary
Alan Ezekowitz currently owns a total of 2 stocks. Among these stocks, Alan Ezekowitz owns 117,420 shares of Septerna Inc (SEPN) as of March 7, 2025, with a value of $4 Million and a weighting of 98.98%. Alan Ezekowitz also owns 10,927 shares of Fulcrum Therapeutics Inc (FULC) as of June 26, 2026, with a value of $40,703 and a weighting of 1.02%.
Latest Holdings of Alan Ezekowitz
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SEPN | Septerna Inc | 2025-03-07 | 117,420 | 33.50 | 3,933,570 |
| FULC | Fulcrum Therapeutics Inc | 2026-06-26 | 10,927 | 3.73 | 40,703 |
Holding Weightings of Alan Ezekowitz
Alan Ezekowitz Form 4 Trading Tracker
According to the SEC Form 4 filings, Alan Ezekowitz has made a total of 2 transactions in Septerna Inc (SEPN) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Septerna Inc is the acquisition of 13,319 shares on March 7, 2025, which cost Alan Ezekowitz around $92,301.
According to the SEC Form 4 filings, Alan Ezekowitz has made a total of 1 transactions in Fulcrum Therapeutics Inc (FULC) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Fulcrum Therapeutics Inc is the sale of 18,000 shares on June 26, 2026, which brought Alan Ezekowitz around $65,700.
Insider Trading History of Alan Ezekowitz
* The information on this page (including Insider Trading Shares, Share Changes, Cost, etc.) is sourced exclusively from Form 4 filings and does not incorporate any data from 13F or 13D/G filings. As a result, it may differ from the values shown on the Guru page.
- 1
Alan Ezekowitz Trading Performance
GuruFocus tracks the stock performance after each of Alan Ezekowitz's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Alan Ezekowitz is 59.66%. GuruFocus also compares Alan Ezekowitz's trading performance to market benchmark return within the same time period. The performance of stocks bought by Alan Ezekowitz within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Alan Ezekowitz's insider trading performs compared to the benchmark.
Performance of Alan Ezekowitz
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -15.09 | | | | | |
| Relative Return to S&P 500(%) | -3.16 | | | | | |
Alan Ezekowitz Ownership Network
Ownership Network List of Alan Ezekowitz
Ownership Network Relation of Alan Ezekowitz
Alan Ezekowitz Owned Company Details
What does Fulcrum Therapeutics Inc do?
Who are the key executives at Fulcrum Therapeutics Inc?
Alan Ezekowitz is the director of Fulcrum Therapeutics Inc. Other key executives at Fulcrum Therapeutics Inc include 10 percent owner Kevin Tang , 10 percent owner Tang Capital Management Llc , and director & President & CEO Robert J Gould .
Fulcrum Therapeutics Inc (FULC) Insider Trades Summary
Over the past 18 months, Alan Ezekowitz made 1 insider transaction in Fulcrum Therapeutics Inc (FULC) with a net sale of 18,000. Other recent insider transactions involving Fulcrum Therapeutics Inc (FULC) include a net sale of 60,000 shares made by Robert J Gould , a net purchase of 417,562 shares made by Kevin Tang , and a net sale of 4,175,139 shares made by Ra Capital Healthcare Fund Lp .
In summary, during the past 3 months, insiders sold 18,000 shares of Fulcrum Therapeutics Inc (FULC) in total and bought 417,562 shares, with a net purchase of 399,562 shares. During the past 18 months, 4,257,089 shares of Fulcrum Therapeutics Inc (FULC) were sold and 417,562 shares were bought by its insiders, resulting in a net sale of 3,839,527 shares.
Fulcrum Therapeutics Inc (FULC)'s detailed insider trading history can be found in Insider Trading Tracker table.
Fulcrum Therapeutics Inc Insider Transactions
Alan Ezekowitz Mailing Address
Above is the net worth, insider trading, and ownership report for Alan Ezekowitz. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Alan Ezekowitz's mailing address is: Cambridge Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
